Overall survival benefit for patients with relapsed Hodgkin lymphoma treated with brentuximab vedotin after autologous stem cell transplant Meeting Abstract
| Authors: | Karuturi, M. S.; Arai, S.; Chen, R. W.; Gopal, A. K.; Feng, L.; Yuan, Y.; Smith, S. E.; Ansell, S. M.; Rosenblatt, J. D.; Savage, K. J.; Ramchandren, R.; Bartlet, N. L.; Cheson, B. D.; Forero-Torres, A.; Moskowitz, C. H.; Connors, J. M.; Fanale, M. A.; de Vos, S.; Engert, A.; Illidge, T.; Borchmann, P.; Morschhauser, F.; Horning, S. J.; Younes, A. |
| Abstract Title: | Overall survival benefit for patients with relapsed Hodgkin lymphoma treated with brentuximab vedotin after autologous stem cell transplant |
| Meeting Title: | 54th Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 120 |
| Issue: | 21 |
| Meeting Dates: | 2012 Dec 8-11 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2012-11-01 |
| Language: | English |
| ACCESSION: | WOS:000314049600217 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V120.21.3701.3701 |
| Notes: | --- - Meeting Abstract: 3701 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos" |
